Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 03 11:18AM ET
24.68
Dollar change
-0.27
Percentage change
-1.10
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y20.88% Shs Outstand Perf Week-1.19%
SponsorBlackrock (iShares) ETF Type Tagsequity Return% 3Y- Total Holdings66 Perf Month-0.61%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM3.75M Perf Quarter5.69%
IndexNYSE FactSet Global Neuro Biopharma and... Average Maturity Tagsinnovation Return% 10Y NAV% Perf Half Y-0.86%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year19.52%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range19.08 - 26.90 Perf YTD-5.89%
Dividend TTM0.01 (0.03%) ESG Type Tags- Flows% 3M0.00% 52W High-8.23% Beta0.72
Dividend Ex-DateDec 20, 2023 Dividend Type Sector/Theme Flows% YTD0.00% 52W Low29.38% ATR (14)0.25
Expense0.47% Structure Type Region Flows% 1Y RSI (14)45.74 Volatility0.28% 0.28%
Option/ShortYes / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.46 Prev Close24.96
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.71K Price24.68
SMA20-0.22% SMA50-1.78% SMA200-0.70% Trades Volume207 Change-1.10%
iShares Neuroscience and Healthcare ETF seeks to track the NYSE FactSet Global Neuro Biopharma and MedTech Index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience. The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified.